J. Kevin Buchi, Director at Ampio Pharmaceuticals, Inc. (AMPE), bought 32,534 shares at $0.27 ($9K) on 2023-05-16, disclosed to the SEC on 2023-05-17.
Open-market purchase of $9k AMPE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| AMPE | BUY | 2023-05-16 | $17K | — | Filing → |
| TLOG | BUY | 2015-03-30 | $21K | — | Filing → |
| TLOG | BUY | 2015-01-09 | $25K | — | Filing → |